Compounds > carbon tetrachloride
Page last updated: 2024-08-17

carbon tetrachloride and sr141716

carbon tetrachloride has been researched along with sr141716 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Bernardi, M; Caraceni, P; Croci, T; Domenicali, M; Giannone, F; Pertosa, AM; Principe, A; Trevisani, F; Zambruni, A1
Baldassarre, M; Bernardi, M; Caraceni, P; Domenicali, M; Giannone, FA; Trevisani, F; Zaccherini, G1

Other Studies

3 other study(ies) available for carbon tetrachloride and sr141716

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis.
    Gastroenterology, 2009, Volume: 137, Issue:1

    Topics: Animals; Ascites; Blood Pressure; Carbon Tetrachloride; Cardiac Output; Diuresis; Dose-Response Relationship, Drug; Kidney; Liver Cirrhosis, Experimental; Male; Natriuresis; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Renal Circulation; Rimonabant; Sodium; Sodium, Dietary; Time Factors; Vascular Resistance

2009
Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis.
    Laboratory investigation; a journal of technical methods and pathology, 2012, Volume: 92, Issue:3

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Drug Evaluation, Preclinical; Extracellular Matrix; Hepatic Stellate Cells; Liver Cirrhosis, Experimental; Male; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Remission Induction; Rimonabant

2012